Indivior Declares $8.13 Special Dividend Tied to Supernus Merger Close
INDV sits 63% above its 52-week low of $22.22.
Summary
Indivior's board declared a special cash dividend of $8.13 per share, payable to holders of record on October 30, 2026, contingent on the closing of its merger with Supernus Pharmaceuticals expected November 2, 2026. Payment is anticipated on or about November 6, 2026. This formalizes the $1 billion special dividend previously disclosed in the S-4 filing, now with specific per-share amount and dates. The dividend represents a significant return of capital to Indivior shareholders, funded by additional indebtedness as noted in the merger documents. The shareholder vote on the merger is scheduled for October 15, 2026, and the dividend will not be paid if the merger fails to close.
At the time of this announcement, INDV was trading at $36.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $22.22 to $42.81. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.